RFPs
Vanderbilt University
High Throughput Screening Assays to Map Macrocyclic Peptide Permeability and Stability Properties

High Throughput Screening Assays to Map Macrocyclic Peptide Permeability and Stability Properties

Vanderbilt University

AstraZeneca is seeking high throughput screening assays to map macrocyclic peptide permeability and stability for oral drug development

Reference No.
RFP-2025-3128
Category
Research/Development
Due Date
March 6th, 2026

Description

AstraZeneca is seeking screening assays or predictive models relevant to oral bioavailability and cell permeability of macrocyclic peptides to help map and model the property space required for oral and cell-permeable macrocyclic therapeutics.

Key Requirements

RFP Submission Requirements for Vanderbilt Peptide Assays

Contact Information

What you’ll get when you unlock

All the details after a short form. No spam

  • Latest RFP PDF
  • Buyer contact sheet
  • Submission checklist
  • Any addenda links

Fill in your details we'll send you your RFP

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.